The chemical class known as EG667693 inhibitors encompasses a range of compounds characterized by their ability to modulate the function of specific protein targets. These inhibitors often possess structural features that allow them to interact selectively with their intended biological targets, thereby inhibiting specific pathways or enzymatic activities. EG667693 inhibitors typically exhibit a high degree of specificity, achieved through carefully designed molecular scaffolds, which ensure precise binding to the active site or allosteric regions of their target proteins. This specificity is crucial for studying the mechanisms of action of the targeted proteins in various biological processes. The chemical structures of these inhibitors may include aromatic rings, hydrogen bond donors and acceptors, and heterocyclic motifs, contributing to their stability, binding affinity, and the ability to penetrate cell membranes effectively. The functional groups present in these compounds are often carefully chosen to optimize solubility and bioavailability in experimental settings.
Furthermore, EG667693 inhibitors are frequently used as tools in biochemical research to dissect the role of the target proteins in signaling pathways, cellular metabolism, and gene regulation. By inhibiting the activity of specific proteins, researchers can observe resulting changes in cellular processes, providing valuable insight into protein function and pathway dynamics. These inhibitors are typically characterized by their ability to inhibit with high potency, often demonstrated by low IC50 values in enzymatic assays. The potency and specificity of EG667693 inhibitors make them suitable for use in a variety of experimental contexts, including in vitro studies, cell-based assays, and structural biology experiments. Given their detailed chemical design and application in research, these compounds are essential for elucidating complex biochemical networks and understanding protein-protein interactions at the molecular level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $62.00 $260.00 | 21 | |
An antifungal agent that inhibits steroid synthesis, possibly affecting androgen levels and indirectly spermatogenesis. | ||||||
Trilostane | 13647-35-3 | sc-208469 sc-208469A | 10 mg 100 mg | $224.00 $1193.00 | 2 | |
An inhibitor of 3β-hydroxysteroid dehydrogenase, potentially disrupting steroidogenesis and spermatogenesis. | ||||||
Mitotane | 53-19-0 | sc-205754 sc-205754A | 100 mg 1 g | $71.00 $163.00 | 1 | |
An adrenolytic compound that can alter steroid hormone biosynthesis, potentially impacting the hormonal control of Spata31e4 expression. | ||||||
Finasteride | 98319-26-7 | sc-203954 | 50 mg | $103.00 | 3 | |
A 5α-reductase inhibitor that reduces dihydrotestosterone levels, possibly influencing spermatogenesis where Spata31e4 plays a role. | ||||||
Dutasteride | 164656-23-9 | sc-207600 | 10 mg | $167.00 | 2 | |
Similar to Finasteride, it inhibits 5α-reductase but is more potent, potentially affecting Spata31e4 expression or function. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $107.00 | 3 | |
An aldosterone antagonist with potential antiandrogenic effects, capable of affecting hormonal regulation of spermatogenesis. | ||||||
Flutamide | 13311-84-7 | sc-204757 sc-204757A sc-204757D sc-204757B sc-204757C | 1 g 5 g 25 g 500 g 1 kg | $46.00 $153.00 $168.00 $515.00 $923.00 | 4 | |
A nonsteroidal antiandrogen that can interfere with androgen receptor signaling, potentially affecting Spata31e4-related processes. | ||||||
MDV3100 | 915087-33-1 | sc-364354 sc-364354A | 5 mg 50 mg | $240.00 $1030.00 | 7 | |
A more potent antiandrogen that can interfere with multiple steps in androgen receptor signaling, potentially affecting Spata31e4 function. | ||||||
Bicalutamide | 90357-06-5 | sc-202976 sc-202976A | 100 mg 500 mg | $41.00 $143.00 | 27 | |
A nonsteroidal antiandrogen that can block androgen receptor activity, potentially modulating Spata31e4's role in spermatogenesis. | ||||||
Letrozole | 112809-51-5 | sc-204791 sc-204791A | 25 mg 50 mg | $85.00 $144.00 | 5 | |
An aromatase inhibitor that can reduce estrogen levels, potentially impacting the hormonal environment influencing Spata31e4. |